NEOGENOMICS INC (NEO)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NEO
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NEO | Board Member | 57 | ["Senior Vice President, Head of Oncology Global Clinical Development at Merck & Co. Inc.","Senior Vice President of Late Stage Oncology at Seagen","Licensed physician","Clinical researcher and physician treating oncology patients","Faculty member of The University of Texas MD Anderson Cancer Center","Approximately twelve years' experience in clinical research","Approximately fourteen years' experience as a clinical drug development leader","Expertise in selection and use of biomarkers for treatment","Strategy/Business Development / M&A","Human Resources/ Organizational Development","Legal / Governance / Business Conduct","Risk Management","Public Policy / Regulatory Affairs"] | ["Audit and Finance Committee"] | 2026 |